Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 4)

Adenocarcinoma of Lung (Phase 2)

Ascites (Phase 2)

Bile Duct Neoplasms (Phase 2)

Biliary Tract Neoplasms (Phase 2)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Ductal (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 3)

Carcinoma, Transitional Cell (Phase 2)

Cholangiocarcinoma (Phase 2)

Colorectal Neoplasms (Phase 3)

Disease Progression (Phase 2)

Esophageal Neoplasms (Phase 2)

Esophageal Squamous Cell Carcinoma (Phase 3)

Gallbladder Neoplasms (Phase 2)

Gastrointestinal Neoplasms (Phase 2)

Head and Neck Neoplasms (Phase 2)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Second Primary (Phase 2)

Neoplasms, Squamous Cell (Phase 3)

Neuroendocrine Tumors (Phase 2)

Pancreatic Neoplasms (Phase 3)

Peritoneal Neoplasms (Phase 2)

Rectal Neoplasms (Phase 2)

Sarcoma (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Stomach Neoplasms (Phase 2)

Thromboembolism (Phase 3)

Urinary Bladder Neoplasms (Phase 2)

Venous Thromboembolism (Phase 3)